http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109020980-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2017-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109020980-B |
| titleOfInvention | Pyrazolopyrimidine dinitrogen derivative with anti-tumor effect |
| abstract | The invention relates to the field of medicine, and discloses pyrazolopyrimidine dinitrogen shown as a structural formula I Derivatives of aurora A, aurora B, and VEGFR2 2 KDR) or two or one of the three targets has obvious inhibiting effect, and pharmacological experiments show that the compound has obvious anti-tumor activity, can be used for developing anti-tumor medicaments for treating or controlling malignant tumors, and particularly can be used for treating or controlling gastric cancer, liver cancer, lung cancer, breast cancer, colon cancer and the like. |
| priorityDate | 2017-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 187.